Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

被引：44
|
作者：
Prebet, Thomas [1 ,2 ,3 ]
Gore, Steven D. [1 ,3 ]
Thepot, Sylvain [3 ]
Esterni, Benjamin [2 ]
Quesnel, Bruno [3 ]
Rauzy, Odile Beyne [3 ]
Dreyfus, Francois [3 ]
Gardin, Claude [3 ]
Fenaux, Pierre [3 ]
Vey, Norbert [2 ,3 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Hematol Malignancies, Baltimore, MD 21218 USA
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[3] Grp Francophone Myelodysplasies, Bobigny, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 06期
关键词：
Myelodysplasia; acute myeloid leukaemia; azacitidine; relapse; outcome; CONVENTIONAL CARE REGIMENS;
D O I：
10.1111/j.1365-2141.2012.09076.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 766
页数：3
相关论文
共 50 条
  • [31] SUCCESSFULL AZACITIDINE BASED TREATMENT OF THERAPY RELATED MYELODYSPLASTIC SYNDROME WITH NORMAL KARYOTYPE OCCURRED AFTER ACUTE MYELOID LEUKEMIA
    Saltarelli, F.
    Tatarelli, C.
    Naso, V.
    Spiriti, M.
    Bianchi, M.
    Conte, E.
    Ferrari, A.
    HAEMATOLOGICA, 2013, 98 : 590 - 590
  • [32] Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Cluzeau, Thomas
    Furstoss, Nathan
    Savy, Coline
    El Manaa, Wejdane
    Zerhouni, Marwa
    Blot, Lauriane
    Calleja, Anne
    Dufies, Maeva
    Dubois, Alix
    Ginet, Clemence
    Mounier, Nicolas
    Garnier, Georges
    Raynaud, Sophie
    Rohrlich, Pierre Simon
    Peterlin, Pierre
    Stamatoullas, Aspasia
    Chermat, Fatiha
    Fenaux, Pierre
    Jacquel, Arnaud
    Robert, Guillaume
    Auberger, Patrick
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [33] AntineoplasticsLoss of response to azacitidine, acute promyelocytic leukaemia and myelodysplastic syndrome: case report
    Reactions Weekly, 2015, 1577 (1) : 35 - 35
  • [34] EtoposideFatal myelodysplastic syndrome and acute myeloid leukaemia: case report
    Reactions Weekly, 2002, 925 (1) : 7 - 8
  • [35] Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome
    Iacobucci, Ilaria
    Mullighan, Charles G.
    CURRENT OPINION IN HEMATOLOGY, 2021, 28 (02) : 101 - 109
  • [36] Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients
    Petit, C.
    Saillard, C.
    Mohty, B.
    Hicheri, Y.
    Villetard, F.
    Maisano, V.
    Charbonnier, A.
    Rey, J.
    D'Incan, E.
    Rouzaud, C.
    Gelsi-Boyer, V.
    Murati, A.
    Lhoumeau, A. C.
    Ittel, A.
    Mozziconacci, M. J.
    Alary, A. S.
    Hospital, M. -A.
    Vey, N.
    Garciaz, S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (04) : 530 - 537
  • [37] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [38] Azacitidine A Review of its Use in Higher-Risk Myelodysplastic Syndromes/Acute Myeloid Leukaemia
    Keating, Gillian M.
    DRUGS, 2009, 69 (17) : 2501 - 2518
  • [39] Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities
    Wanquet, Anne
    Prebet, Thomas
    Berthon, Celine
    Sebert, Marie
    Roux, Clemence
    Kulasekararaj, Austin
    Micol, Jean-Baptiste
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Recher, Christian
    Delaunay, Jacques
    Dreyfus, Francois
    Mufti, Ghulam
    Fenaux, Pierre
    Vey, Norbert
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 859 - 863
  • [40] Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia
    Winters, Amanda C.
    Maloney, Kelly W.
    Treece, Amy L.
    Gore, Lia
    Franklin, Anna K.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (10)
12345